Skip to Main Content

Paper Details

Refining the definition of biochemical failure in the era of stereotactic body radiation therapy for prostate cancer: The Phoenix definition and beyond.
Radiother Oncol
6
2022
BCF, BCFs, PCa, PSA, Patients, nPSA, nPSA +, nPSA + 2, nPSAs, patients, prostate cancer, rPSA
Brachytherapy, Humans, Male, Prostate-Specific Antigen, Prostatic Neoplasms, Radiosurgery, Retrospective Studies
Author NameAffiliation
Ting Martin MaUniversity of California Los Angeles
Soumyajit RoyRush University Medical Center
Xue WuPenn State College of Medicine
Constantine A Mantz
Donald B Fuller
Leszek MiszczykMaria Sklodowska-Curie National Research Institute of Oncology Gliwice Branch
Alexandra NapieralskaMaria Sklodowska-Curie National Research Institute of Oncology Gliwice Branch
Agnieska Namys??-KaletkaMaria Sklodowska-Curie National Research Institute of Oncology Gliwice Branch
Hilary P BagshawStanford University School of Medicine
Mark K BuyyounouskiStanford University School of Medicine
Rachel M GlicksmanUniversity of Toronto
D Andrew LoblawOdette Cancer Centre
Alan W KatzSt. Francis Hospital
Shrinivasa K UpadhyayaUniversity of California davis
Nicholas G NickolsUniversity of California Los Angeles
Michael L SteinbergUniversity of California Los Angeles
Rebecca PhilipsonTorrance Memorial Hospital
Nima AghdamBeth Israel Deaconess Medical Center
Simeng SuyGeorgetown University Hospital
Abigail PepinUniversity of Pennsylvania Health System
Sean P CollinsGeorgetown University Hospital
Paul C BoutrosUniversity of Pennsylvania Health System
Matthew B RettigUniversity of California Los Angeles
Jeremie CalaisUniversity of California Los Angeles
Ming WangPenn State College of Medicine
Nicholas G ZaorskyUniversity Hospitals Seidman Cancer Center, Case Western Reserve University
Amar U KishanUniversity of California Los Angeles
  • 1 - 27

Datasets

Release 1.2